Dr. Kate Williamson

Kate Williamson screenshot

Brief Biography:

Kate carried out her medical studies at the University of Adelaide, Australia, completing her MBBS in 2005. She went on to undertake her specialty training in basic physician training and subsequently advanced training in gastroenterology and hepatology through the Royal Australasian College of Physicians, completing her specialisation in 2013.

While performing a one year Senior Clinical Fellowship at the Translational Gastroenterology Unit (TGU) at the John Radcliffe Hospital in Oxford, she became interested in clinical and translational research, particularly in the area of inflammatory bowel disease and autoimmune liver disease, and carried out various clinical audit studies in primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). She went on to join Satish Keshav’s laboratory undertaking research into biomarkers in Crohn’s disease, before commencing her DPhil in Clinical Medicine in 2015 with the Nuffield Department of Medicine, under the supervision of Satish Keshav, Paul Klenerman, and Roger Chapman.

She currently holds a Wellcome Trust Clinical Research Fellowship, and is also a sub-investigator on several trials in PBC, PSC, and inflammatory bowel disease. She is a member of the International PSC Study Group, and collaborates on various national and international studies in PSC.

Research interests:

Inflammatory Bowel Disease, Primary Sclerosing Cholangitis, flow cytometry, immunohistochemistry

Current project:

Peripheral blood, Liver and Intestine-specific lymphocytes in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

Publications:

1. Williamson KD, Chapman RW. New Therapeutic Strategies for Primary Sclerosing Cholangitis. Seminars in Liver Disease 2015.36(1):5-14.

2. Carbone M, Sharp SJ, Flack S, Paximadas D, Spiess K, Adgey C, Griffiths L,Lim R, Trembling P, Williamson KD, et al. The UK-PBC Risk Score: derivation and validation of a risk score to predict the need for liver transplantation in patients with PBC. Hepatology 2015. 63 (3): 930-950. 

3. Williamson KD, Steveling K, Holtmann G, Schoeman M, Andrews JM. Clinical triage for colonoscopy is useful in young women. Internal Medicine Journal 2015; 45:492-96.

4. Williamson KD, Chapman RW. Primary Sclerosing Cholangitis: A Clinical Update. British Medical Bulletin 2015; 114:53-64.

5. Williamson KD, Chapman RW. Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC. Alimentary Pharmacology & Therapeutics 2015;41:149-151.

6. Williamson KD, Chapman RW. Primary Sclerosing Cholangitis. Dig Diseases 2014;32:438-445

7. Bryant RV, Kuo P, Williamson KD, Yam C, Schoeman MN, Holloway RH.Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding. Gastroint Endoscopy 2013; 78: 576-83.

8. Williamson KD, Nguyen N. A Large Shin Ulcer After Minor Trauma: Please Do Not Debride! Gastroenterology 2012, Vol 143, Issue 4, Pages e11-e12.

9. Chapman RW, Williamson KD. Primary Sclerosing Cholangitis. In: Baumgart D, ed. Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach, Second Edition. 2015.  ISBN 978-3-319-33701-2

10. Williamson KD, Chapman RW. Primary Sclerosing Cholangitis. In: Warrell DA, Cox T, Firth J, eds. Oxford textbook of medicine, 5th ed. [electronic resource], 2010, updated November 2012. DOI: 10.1093/med/9780199204854.003.152104_update_001